ArticlePloS one2026
Hydrogel-based co-culture and application of two types of islet cells.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to develop a hydrogel-based co-culture system for pancreatic α- and β-cells to mimic native islet composition and achieve bidirectional blood glucose regulation. Monodisperse sodium alginate microsphere encapsulating α-TC6 and β-TC6 cells in a 2:8 ratio were fabricated using a microfluidic electrostatic spray platform. Key processing parameters (voltage, collection distance, flow rate, and alginate concentration) were optimized to precisely control microsphere diameter, yielding highly uniform spheres with excellent monodispersity. The alginate hydrogel exhibited favorable swelling properties and viscoelasticity, providing a supportive 3D microenvironment. In vitro, the microspheres demonstrated high biocompatibility, with cell viability exceeding 95% after 72 hours of co-culture. Encapsulation did not impair cellular function, as evidenced by unhindered insulin and glucagon secretion compared to unencapsulated controls, in streptozotocin-induced diabetic C57BL/6 mice, transplantation of these cell-laden microspheres into the subcutaneous brown fat significantly improved glucose homeostasis. Treated mice showed markedly better glucose tolerance during intraperitoneal glucose tolerance tests and maintained lower fasting blood glucose levels compared to sham-operated and unencapsulated cell transplantation groups. Furthermore, the treatment alleviated diabetes-associated weight loss, with the microsphere group showing a significant weight increase post-transplantation. Histological analysis confirmed the biocompatibility of the implants, with no significant pathological changes in major organs. In conclusion, this sodium alginate microsphere system effectively co-cultures functional islet cells, provides immunoisolation, and restores bidirectional glucose regulation in a diabetic mouse model, offering a promising strategy for pancreatic islet modeling and cell- based diabetes therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.